Other specified aplastic anemias and other bone marrow failure syndromes
ICD-10 D61.8 is a billable code used to indicate a diagnosis of other specified aplastic anemias and other bone marrow failure syndromes.
D61.8 encompasses a variety of conditions characterized by the failure of the bone marrow to produce adequate blood cells, leading to aplastic anemia and other related syndromes. Aplastic anemia is a rare but serious disorder where the bone marrow fails to produce sufficient amounts of red blood cells, white blood cells, and platelets, resulting in symptoms such as fatigue, increased risk of infections, and bleeding tendencies. This condition can be acquired through exposure to certain chemicals, drugs, or infections, or it may be idiopathic, with no known cause. Other bone marrow failure syndromes included under this code may involve genetic disorders or secondary effects from other diseases. The clinical management of these conditions often requires a multidisciplinary approach, including hematology, oncology, and supportive care to manage symptoms and complications. Accurate diagnosis and coding are crucial for appropriate treatment and reimbursement.
Detailed patient history, lab results, and treatment plans.
Diagnosis of aplastic anemia, management of bone marrow failure syndromes.
Ensure all relevant lab tests and patient symptoms are documented to support coding.
Comprehensive treatment records, including chemotherapy and transfusion details.
Management of secondary aplastic anemia due to cancer treatments.
Document any malignancies that may contribute to bone marrow failure.
Used to monitor blood cell levels in patients with aplastic anemia.
Document the reason for the CBC and any relevant symptoms.
Hematologists should ensure that all relevant lab results are included in the patient's record.
D61.8 is used for other specified aplastic anemias that do not fall under the more specific category of drug-induced aplastic anemia, which is coded as D61.1.
